You are here

  • Home
  • Archive
  • Volume 69, Issue 6
  • Seven-day vonoprazan and low-dose amoxicillin dual therapy as first-line Helicobacter pylori treatment: a multicentre randomised trial in Japan

Article metrics

Article menu

Download PDFPDF

XML
Helicobacter pylori
Original research
Seven-day vonoprazan and low-dose amoxicillin dual therapy as first-line Helicobacter pylori treatment: a multicentre randomised trial in Japan

 

Online download statistics by month:

Online download statistics by month: January 2020 to March 2024

AbstractFullPdf
Jan 202011121065472
Feb 202011101091411
Mar 2020885855215
Apr 2020708694341
May 202010941075430
Jun 2020548538257
Jul 2020566554153
Aug 2020294285119
Sep 2020292284268
Oct 202026526286
Nov 2020272269113
Dec 2020271270118
Jan 202126025571
Feb 202124923395
Mar 2021278270106
Apr 202127726279
May 202124725075
Jun 202123323983
Jul 202125623996
Aug 202116215372
Sep 202122121595
Oct 202119019387
Nov 2021235219115
Dec 202120020070
Jan 202222922277
Feb 202226026776
Mar 2022346346105
Apr 202225425384
May 2022458447124
Jun 2022424424114
Jul 202239037592
Aug 202236434162
Sep 202237337051
Oct 202239838585
Nov 202237735471
Dec 202230929262
Jan 202329226664
Feb 202330928364
Mar 202333831491
Apr 202327324585
May 202330125478
Jun 202326024762
Jul 202335834359
Aug 202333032369
Sep 202345743578
Oct 202335535360
Nov 202330128959
Dec 202316315142
Jan 2024908653
Feb 202411611246
Mar 2024175157148
Total18525179046088